| Literature DB >> 29930262 |
Karen Uhde1, Helena T A van Tol1, Tom A E Stout1,2, Bernard A J Roelen3,4.
Abstract
Cumulus cells are essential for nutrition of oocytes during maturation. In the absence of cumulus cells during maturation, oocyte developmental competence is severely compromised. In this study, we matured bovine cumulus-oocyte-complexes (COCs) for 8 h, the cumulus cells were removed and denuded oocytes were further matured for 15 h in either the medium conditioned by the initial 8 h culture, or in fresh unconditioned medium. Denuded oocytes that completed maturation in COC-conditioned medium demonstrated better developmental potential than denuded oocytes that completed maturation in standard maturation medium. An inventory was made of the metabolites secreted by COCs into the maturation medium during the first 8 h, from 8 to 23 h, and during an entire 23 h maturation protocol; the metabolomic changes in the cumulus cells during maturation were also investigated. In maturation medium, 173 biochemical components were detected compared to 369 different metabolites in cumulus cells. Significant changes in metabolomic components were evident in maturation medium and in cumulus cells during maturation, with most of the changes related to amino acid, carbohydrate, and lipid metabolism. The importance of two detected biochemicals, creatine and carnitine, for oocyte maturation was further investigated. The presence of carnitine, but not creatine during oocyte in vitro maturation improved the developmental competence of denuded oocytes.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29930262 PMCID: PMC6013446 DOI: 10.1038/s41598-018-27829-9
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Experimental timeline (a) and developmental assessment after fertilization (b,c). (a) Intact COCs or denuded oocytes were matured for 23 h. Groups of intact COCs were denuded 8 h after the start of maturation and either placed back into their original medium or placed into fresh maturation medium. In addition, maturation media were supplemented with creatine or carnitine as indicated. After 23 h of maturation oocytes were fertilized and 5 days later cleavage was assessed; at day 8 after fertilization, blastocyst formation was assessed. Cleavage percentages of oocytes (b) and blastocyst formation of cleaved oocytes (c) matured differentially; as intact cumulus oocyte complexes (COC) for 23 h; as denuded oocytes (Den Oocytes) for 23 h; or matured as intact COCs for 8 h, denuded and placed back in their own conditioned medium (8 h Cond) or placed into fresh maturation medium (8 h Fresh). Data are presented as mean ± SD. Different letters above bars indicate outcomes that differ significantly (N = 6; P < 0.05).
Figure 2Principal component analyses for (a) bovine cumulus cells at GV stage (white), 8 h (light blue) and 23 h (blue) after start of maturation and (b) control maturation medium (0 h, light pink) and 8 h (dark pink) or 23 h (bordeaux) conditioning with maturing COCs.
Figure 3Venn diagram showing numbers of metabolites with significantly (Welch’s Two-Sample t-Test) altered concentrations in cumulus cells (a,b) and COC-conditioned medium (c,d) at different time points (8 h vs 0 h; 23 h vs 0 h and 23 h vs 8 h). (a) Increased and (b) decreased concentrations in cumulus cells. (c) Increased and (d) decreased concentrations in conditioned maturation medium.
List of biochemical components detected in cumulus cells.
| Cumulus cells | Fold change | |||
|---|---|---|---|---|
| Pathway | Sub Pathway | Biochemical Name | 8 h vs. 0 h | 23 h vs. 8 h |
| Amino Acid | Glycine, Serine, and Threonine Metabolism | betaine |
| 1.40 |
| serine | 1.18 |
| ||
| Glutamate Metabolism | glutamine |
| 1.00 | |
| pyroglutamine |
|
| ||
| Lysine Metabolism | 5-(galactosylhydroxy)-L-lysine | 1.17 |
| |
| 2-aminoadipate |
| 1.26 | ||
| N-trimethyl 5-aminovalerate |
| 0.53 | ||
| Leucine, Isoleucine, and Valine Metabolism | leucine |
| 1.73 | |
| isoleucine |
| 2.17 | ||
| Methionine, Cysteine, SAM, and Taurine Metabolism | N-acetylmethionine | 0.98 |
| |
| hypotaurine |
| 1.52 | ||
| taurine |
|
| ||
| Creatine Metabolism | guanidinoacetate |
| 1.33 | |
| creatine |
|
| ||
| creatinine |
|
| ||
| Glutathione Metabolism | glutathione, reduced (GSH) | 1.49 |
| |
| ophthalmate |
| 0.71 | ||
| Carbohydrate | Glycolysis, Gluconeogenesis, and Pyruvate Metabolism | 3-phosphoglycerate | 1.12 |
|
| phosphoenolpyruvate (PEP) | 1.55 |
| ||
| pyruvate | 1.23 |
| ||
| lactate | 1.26 |
| ||
| glycerate | 1.06 |
| ||
| Disaccharides and Oligosaccharides | lactose |
|
| |
| Nucleotide Sugar | UDP-glucose |
| 0.35 | |
| UDP-galactose |
|
| ||
| Energy | TCA Cycle | citrate | 1.06 |
|
| aconitate [cis or trans] | 1.18 |
| ||
| alpha-ketoglutarate | 1.16 |
| ||
| fumarate |
|
| ||
| malate | 1.61 |
| ||
| Lipid | Fatty Acid Metabolism(Acyl Carnitine) | acetylcarnitine (C2) |
|
|
| octanoylcarnitine (C8) |
| 0.53 | ||
| stearoylcarnitine (C18) |
| 1.04 | ||
| Carnitine Metabolism | carnitine |
| 1.25 | |
| Phospholipid Metabolism | choline | 1.05 |
| |
| glycerophosphorylcholine (GPC) |
|
| ||
| glycerophosphoethanolamine |
|
| ||
| Phosphatidylcholine (PC) | 1-palmitoyl-2-stearoyl-GPC (16:0/18:0) |
|
| |
| 1-palmitoyl-2-alpha-linolenoyl-GPC (16:0/18:3n3) |
|
| ||
| 1,2-dilinoleoyl-GPC (18:2/18:2) |
|
| ||
| 1-linoleoyl-2-linolenoyl-GPC (18:2/18:3) |
|
| ||
| Phosphatidylethanolamine (PE) | 1,2-dipalmitoyl-GPE (16:0/16:0) |
|
| |
| 1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4) |
|
| ||
| 1-oleoyl-2-arachidonoyl-GPE (18:1/20:4) |
|
| ||
| Phosphatidylserine (PS) | 1-palmitoyl-2-oleoyl-GPS (16:0/18:1) | 0.78 |
| |
| 1-stearoyl-2-oleoyl-GPS (18:0/18:1) | 0.74 |
| ||
| Phosphatidylinositol (PI) | 1-palmitoyl-2-arachidonoyl-GPI (16:0/20:4) |
| 0.69 | |
| 1-stearoyl-2-oleoyl-GPI (18:0/18:1) | 1.53 |
| ||
| 1-stearoyl-2-arachidonoyl-GPI (18:0/20:4) |
| 0.78 | ||
| Diacylglycerol | diacylglycerol (12:0/18:1, 14:0/16:1, 16:0/14:1) [2] | 0.76 |
| |
| palmitoyl-palmitoyl-glycerol (16:0/16:0) [2] | 1.02 |
| ||
| linoleoyl-arachidonoyl-glycerol (18:2/20:4) [1] | 1.00 |
| ||
| linoleoyl-arachidonoyl-glycerol (18:2/20:4) [2] | 0.70 |
| ||
| Lipid | Sphingolipid Metabolism | N-palmitoyl-sphinganine (d18:0/16:0) |
| 1.26 |
| N-palmitoyl-sphingadienine (d18:2/16:0) |
| 1.15 | ||
| tricosanoyl sphingomyelin (d18:1/23:0) |
|
| ||
| sphingomyelin (d18:0/18:0, d19:0/17:0) |
|
| ||
| hexadecasphingosine (d16:1) |
| 1.03 | ||
| N-palmitoyl-heptadecasphingosine (d17:1/16:0) |
| 1.01 | ||
| Ceramides | N-palmitoyl-sphingosine (d18:1/16:0) |
| 1.19 | |
| N-stearoyl-sphingosine (d18:1/18:0) |
| 1.07 | ||
| ceramide (d18:1/17:0, d17:1/18:0) |
| 1.08 | ||
Fold changes in component concentration were calculated for cumulus cells after 8 h maturation versus GV stage cumulus cells (0 h), and cumulus cells matured for 23 h versus 8 h. Cells marked in bold indicate a significant increase, and those marked in italic a significant decrease.
List of biochemical components detected in cumulus-oocyte-complex-conditioned medium.
| Maturation medium | Fold change | |||
|---|---|---|---|---|
| Pathway | Sub Pathway | Biochemical Name | 8 h vs. 0 h | 23 h vs. 8 h |
| Amino Acid | Glycine, Serine, and Threonine Metabolism | glycine | 1.05 |
|
| N-acetylglycine | 1.06 |
| ||
| betaine |
| 0.81 | ||
| serine |
|
| ||
| N-acetylserine |
|
| ||
| N-acetylthreonine | 1.00 |
| ||
| Glutamate Metabolism | glutamate | 0.99 |
| |
| N-acetylglutamate |
|
| ||
| N-acetylglutamine |
| 1.46 | ||
| pyroglutamine |
|
| ||
| S-1-pyrroline-5-carboxylate |
| 1.17 | ||
| Leucine, Isoleucine, and Valine Metabolism | N-acetylleucine | 1.11 |
| |
| 4-methyl-2-oxopentanoate |
|
| ||
| 3-methyl-2-oxovalerate |
|
| ||
| 3-methyl-2-oxobutyrate | 1.69 |
| ||
| 3-hydroxyisobutyrate | 1.08 |
| ||
| Methionine, Cysteine, SAM, and Taurine Metabolism | N-acetylmethionine | 2.77 |
| |
| methionine sulfoxide |
| 1.06 | ||
| hypotaurine |
|
| ||
| taurine |
| 0.84 | ||
| Urea cycle; Arginine and Proline Metabolism | urea | 1.02 |
| |
| ornithine |
|
| ||
| 2-oxoarginine |
| 1.38 | ||
| dimethylarginine (SDMA + ADMA) |
|
| ||
| trans-4-hydroxyproline | 0.98 |
| ||
| Creatine Metabolism | guanidinoacetate | 1.18 |
| |
| creatine |
| 1.21 | ||
| creatinine |
| 0.95 | ||
| Glutathione Metabolism | cysteine-glutathione disulfide | 1.32 |
| |
| 2-hydroxybutyrate/2-hydroxyisobutyrate | 1.84 |
| ||
| Carbohydrate | Glycolysis, Gluconeogenesis, and Pyruvate Metabolism | glucose |
|
|
| pyruvate | 1.15 |
| ||
| lactate |
|
| ||
| glycerate |
| 1.38 | ||
| Pentose Metabolism | ribose |
| 1.09 | |
| ribitol |
|
| ||
| ribonate |
| 1.07 | ||
| arabitol/xylitol | 1.65 |
| ||
| Fructose, Mannose, and Galactose Metabolism | fructose |
| 1.04 | |
| mannitol/sorbitol |
| 1.39 | ||
| mannose | 1.03 |
| ||
| Aminosugar Metabolism | erythronate | 1.22 |
| |
| N-acetylglucosamine/N-acetylgalactosamine | 1.00 |
| ||
| Energy | TCA Cycle | citrate |
|
|
| aconitate [cis or trans] | 1.00 |
| ||
| alpha-ketoglutarate |
|
| ||
| succinate |
| 1.49 | ||
| fumarate |
|
| ||
| malate | 1.70 |
| ||
| Lipid | Medium Chain Fatty Acid | heptanoate (7:0) | 0.64 |
|
| Fatty Acid, Dicarboxylate | glutarate (pentanedioate) | 0.68 |
| |
| 2-hydroxyglutarate |
|
| ||
| Carnitine Metabolism | carnitine |
| 0.89 | |
| Inositol Metabolism | myo-inositol |
|
| |
| Phospholipid Metabolism | choline |
| 0.88 | |
| choline phosphate |
| 1.40 | ||
| glycerophosphorylcholine (GPC) | 1.21 |
| ||
| glycerophosphoethanolamine | 1.21 |
| ||
| glycerophosphoinositol | 1.27 |
| ||
| Glycerolipid Metabolism | glycerol |
|
| |
| glycerophosphoglycerol |
|
| ||
| Mevalonate Metabolism | 3-hydroxy-3-methylglutarate |
|
| |
Fold changes in biochemical component concentration were calculated for medium conditioned for 8 h versus unconditioned medium (0 h) and for medium conditioned for 23 h versus 8 h. Cells highlighted in bold exhibited a significant increase, and those highlighted in italic a significant decrease.
Figure 4Cleavage of oocytes (a,b) and blastocyst formation of cleaved oocytes (c,d) matured in carnitine supplemented medium. Oocytes were matured as intact COCs for 23 h (COC) or as intact COCs for 8 h before being denuded and placed back in their own conditioned medium (Cond), or transferred to fresh maturation medium (Fresh) or to fresh maturation medium supplemented with varying concentrations of carnitine. Denuded oocytes were matured for 23 h in conventional medium or for 23 h in carnitine-supplemented medium. Data are presented as mean ± SD. Data points labelled with the same letter did not differ significantly (N = 3; P < 0.05).
Figure 5Cleavage of oocytes (a,b) and blastocyst formation of cleaved oocytes (c,d) matured in creatine supplemented medium. Oocytes were matured as intact COCs for 23 h (COC) or as intact COCs for 8 h before being denuded and placed back in their own conditioned medium (Cond), transferred to fresh maturation medium (Fresh) or into fresh maturation medium supplemented with varying concentrations of creatine. Denuded oocytes were matured for 23 h or for 23 h in creatine-supplemented medium. Data are presented as mean ± SD. Data points labelled with the same letter did not differ significantly (N = 3; P < 0.05).